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Abstract
Background—Complete atrioventricular canal defects (CAVC) are a common heart defect, but
few epidemiologic studies have evaluated nonsyndromic CAVC. Risk factors for nonsyndromic
CAVC have not been well established.
Methods—To assess the relationship between risk for nonsyndromic CAVC in offspring and
several sociodemographic and reproductive parental factors, including maternal diabetes and
obesity, we conducted Poisson regression analyses, using data ascertained through the Texas Birth
Defects Registry, a large, population-based birth defects registry. Data were evaluated for 563
nonsyndromic cases with CAVC.
Results—Significant associations were observed between nonsyndromic CAVC in offspring and
maternal pregestational diabetes (adjusted prevalence ratio (aPR): 6.74, 95% confidence interval
(CI): 3.67–12.37), gestational diabetes [aPR: 1.69, 95% CI: 1.03, 2.79], and obesity [aPR: 1.69,
95% CI: 1.24, 2.30].
Comments—Our findings add nonsyndromic CAVC to the growing list of birth defects that
appear to be associated with maternal diabetes and obesity.
INTRODUCTION
Birth defects are a leading cause of infant mortality.1 Further, congenital heart defects are
the leading cause of birth defect-related mortality and the etiology of heart defects is poorly
understood.2 Heart defects represent a heterogeneous group of malformations, and some
types of heart defects have been better studied than others. Complete atrioventricular canal
defects (CAVC) are the most common type of endocardial cushion defect, and involve
deficiencies of the endocardial cushion-derived components of the atrial and ventricular
septae and a single common atrioventricular valve ring. CAVC represents approximately 3%
of heart defects, occurring in two per 10,000 live births.3 More than 50% of CAVC occur in
conjunction with trisomy 21, and 50% of infants with untreated CAVC, whether syndromic
or nonsyndromic, will die during the first year of life.3, 4 Few epidemiologic studies have
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evaluated nonsyndromic CAVC and risk factors for nonsyndromic CAVC have not been
well established.
Maternal pregestational diabetes, gestational diabetes, and obesity are independently
associated with increased risk for birth defects, including heart defects, in offspring.5, 6
Since more than one-third of adult women in the US are obese or diabetic, and the
prevalence of each is rising,7, 8 it is important to delineate the full range of adverse outcomes
associated with maternal obesity and diabetes. Although animal models suggest that
maternal diabetes may increase offspring risk for CAVC,9 the effects of maternal obesity,
diabetes, or other factors on offspring risk for CAVC have not been well studied in humans.
Therefore, we conducted a descriptive epidemiologic study of CAVC, evaluating the
possible influence of a wide range of sociodemographic and reproductive factors, including
maternal diabetes and obesity, on risk for CAVC.
METHODS
Study Population
We conducted descriptive analyses using CAVC data from the Texas Birth Defects Registry.
This registry is maintained by the Birth Defects Epidemiology and Surveillance Branch
(BDESB) at the Texas Department of State Health Services.10 Active case surveillance is
used to identify live births, fetal deaths, and induced pregnancy terminations with birth
defects. Cases are included in the registry when the mother resides in Texas at the time of
delivery and a diagnosis of a structural malformation or developmental disability is made
within the first year of delivery. Case data are abstracted from medical records at all birthing
centers, delivery hospitals, midwife facilities, and pediatric hospitals in Texas by BDESB
staff. Diagnoses are classified using a six-digit code defined by the Centers for Disease
Control and Prevention, based on the British Pediatric Association Classification of Diseases
and the International Classification of Diseases, 9th Revision, Clinical Modification system
(BPA code).11 Case data from medical records are then linked to sociodemographic and
reproductive data from birth and fetal death certificates from the Texas Vital Statistics Unit
of the Texas Department of State Health Services.
The present analyses included cases from the registry with documented postnatal
confirmation of diagnoses of endocardial cushion defects (BPA code 745.6) from 1999–
2008, including cases that were live births, fetal deaths, and induced pregnancy
terminations. Main analyses focused on those cases with CAVC (BPA code 745.620). Data
were available for maternal variables (maternal age at delivery, race/ethnicity, history of
previous live births, history of previous pregnancies that did not result in live births, onset of
prenatal care during the first trimester [yes versus no], education level, birthplace, residence
in a county bordering Mexico, residence type [e.g., rural], marital status at time of delivery,
pregestational diabetes, gestational diabetes, and prepregnancy body mass index), paternal
variables (paternal age at delivery and race/ethnicity), and case variables (delivery year,
season of conception, plurality of the pregnancy, and sex). Residence type was defined
based on county population size (i.e., rural urban continuum code), as described by Langlois
et al.12 Season of conception was based on month of last menstrual period and was
categorized as winter (December-February), spring (March-May), summer (June-August),
and fall (September-November). Information on overall presence or absence of maternal
diabetes, regardless of pregestational or gestational onset, was available for the entire study
period. Specific information on maternal pregestational diabetes, gestational diabetes, and
prepregnancy body mass index (BMI) was only available for deliveries in 2005–2008. Data
on type of pregestational diabetes (i.e., type 1 versus type 2) were not available. For all of
these variables, data from vital records were used; however, when data were missing or
when a vital record was not available for a case, data abstracted from medical records were
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used to determine: maternal age at delivery, race/ethnicity, history of previous live births,
residence in a county bordering Mexico, and residence type, and infant sex, plurality, and
year of delivery. In order to make comparisons, vital records data were obtained from the
Texas Vital Statistics unit of the Texas Department of State Health Services for all live
births in Texas during the study period.13 The protocol for this study was approved by the
Institutional Review Board for the University of Texas Health Science Center at Houston.
Statistical Methods
We conducted descriptive analyses to identify sociodemographic or reproductive
characteristics that may increase risk for CAVC. First, we tabulated frequencies of cases
with syndromic and nonsyndromic endocardial cushion defects, including CAVC.
Syndromic cases were defined as cases with possible or confirmed diagnoses of a
chromosome abnormality or malformation syndrome or sequence, based on BPA codes.
Patients with visceral heterotaxy were included in the nonsyndromic group. To limit
heterogeneity, all subsequent analyses were conducted among cases with nonsyndromic
CAVC. Among these nonsyndromic cases, frequencies of additional major birth defects,
including heterotaxy, were determined.
We estimated birth prevalence and crude prevalence ratios using data from cases in the
numerator and data from all live births in the denominator. Poisson regression was used to
estimate prevalence ratios. Variables that were available for the entire study period and were
significantly associated (p<0.05) or associated with borderline significance (i.e., lower 95%
confidence interval limit ≥0.99 for positive associations or upper 95% confidence limit
≤1.01 for negative associations) with nonsyndromic CAVC in crude analyses were included
in the main multivariable model. Multivariable analyses were repeated for deliveries during
2005–2008, using the maternal gestational diabetes, pregestational diabetes, and BMI
variables instead of the overall diabetes variable. For this analysis, we included all other
variables in the original multivariable model. All analyses were performed using SAS
(version 9.1 copyright 2002–2008, SAS, Inc., Cary, NC).
Visceral heterotaxy has been associated with maternal pregestational diabetes and is often
observed in conjunction with CAVC.5, 14 Therefore, analyses for 2005–2008 deliveries and
the full study period were also repeated among cases without heterotaxy, to ensure that any
observed associations were independent of associations with heterotaxy. Further, analyses
for the full study period were also repeated among a small subset of cases with isolated
CAVC (i.e., those without any additional major [cardiac or non-cardiac] birth defects).
RESULTS
There were 3,806,299 total live births and 1,588 total cases with documented postnatal
diagnoses of endocardial cushion defects from 1999–2008 (Table 1). There were 1,335 cases
with CAVC; therefore, the total prevalence of CAVC was 3.51 per 10,000 live births. The
majority of cases with CAVC (58%) had chromosome abnormalities or malformation
syndromes (Table 1), the most common being trisomy 21 (52%, N=693). Cases with
heterotaxy syndrome were included under nonsyndromic CAVC (NSCAVC). Subsequent
analyses focused on cases with NSCAVC (N=563). The prevalence of NSCAVC was 1.48
per 10,000 live births.
The proportion of cases with NSCAVC that were live births, fetal deaths, and induced
terminations were 98.6%, 0.4%, and 1.1%, respectively. There were two fetal deaths and six
induced terminations. Associated major birth defects in the NSCAVC cases are presented by
system or structure in Table 2 (and defined in Supplementary Table 1). Heterotaxy
syndrome was present in 38.7% (N= 218) of the NSCAVC cases. Additional congenital
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heart defects commonly reported in the NSCAVC cases included persistent left superior
vena cava (25.4%, N=143), transposition of the great vessels (39.4%, N=222), persistent
right aortic arch (19%, N=107), ostium secundum atrial septal defect (32.5%, N=183),
hypoplastic left ventricle (18.5%, N=104), total anomalous pulmonary venous return
(18.5%, N=104), and hypoplastic right ventricle (8.0%, N=45).
The variables that were significantly associated with NSCAVC in offspring in the main
crude analyses (i.e., for the entire study period) were maternal age, paternal age, marital
status, plurality, and maternal diabetes (i.e., pregestational or gestational) (Table 3). These
variables were all included in the main multivariable model (Table 4). A significantly
increased prevalence of NSCAVC in offspring was seen among women who were not
married at time of delivery compared to those who were married [adjusted prevalence ratio
(aPR): 1.31, 95% confidence interval (CI): 1.03, 1.66]. In addition, the prevalence of
NSCAVC in offspring was also increased among women with diabetes (pregestational or
gestational) compared to those without diabetes [aPR: 2.63, 95% CI: 1.87, 3.70].
To further explore the relationship between maternal diabetes and NSCAVC in offspring,
we repeated analyses using data only from 2005–2008, which included maternal gestational
diabetes, pregestational diabetes, and BMI variables (Table 4). In the multivariable model, a
significantly increased prevalence of NSCAVC in offspring was observed among women
with pregestational diabetes [aPR: 6.74, 95% CI: 3.67, 12.37] or gestational diabetes [aPR:
1.69, 95% CI: 1.03, 2.79] as well as among obese (i.e., BMI ≥30 kg/m2) women [aPR: 1.69,
95% CI: 1.24, 2.30], compared to women without these conditions.
Because heterotaxy in offspring has previously been associated with maternal diabetes,5 we
repeated analyses among 345 cases without heterotaxy, and in these analyses, similar
magnitudes of associations with diabetes and obesity were observed (Table 4). Further, a
similar magnitude of association with diabetes was observed in analyses repeated for the full
study period among the 47 cases with isolated CAVC (Table 4). Analyses were not repeated
for 2005–2008 among cases with isolated CAVC because there were only 18 such cases
during this period.
DISCUSSION
The overall prevalence of CAVC in the present study was similar to that reported in
previous studies.15, 16 Further, the distribution of syndromes among cases with syndromic
CAVC was similar to previous reports, as was the distribution of additional major birth
defects among nonsyndromic cases.14, 15
Maternal pregestational diabetes is a known risk factor for congenital heart defects overall,
as well as for several specific subtypes of congenital heart defects (e.g, conotruncal defects
and heterotaxia).5, 17–20 However, many previous studies have been limited by small
numbers of cases with specific congenital heart defect subtypes. Due to the rarity of
nonsyndromic CAVC, potential risk factors, including maternal diabetes, have not been well
studied in relation to nonsyndromic CAVC.
In the present study, we found an increased prevalence of nonsyndromic CAVC in offspring
of women with pregestational diabetes, gestational diabetes, obesity (BMI ≥30), or
unmarried marital status at delivery. We are aware of only one other study that evaluated the
descriptive epidemiology of nonsyndromic CAVC.14 In that study, based on data from the
National Birth Defects Prevention Study (N=122 cases), a lower prevalence of CAVC was
seen in offspring of Hispanic mothers [crude PR: 0.4, 95% CI: 0.2, 0.7].14 A similar
association was not observed in the present study, which used a study population with more
than five times as many cases with Hispanic mothers. Although a borderline significant
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higher prevalence of CAVC was seen among multiple compared to single gestation
pregnancies in the present study [aPR: 1.6, 95% CI: 1.0, 2.5] (Table 4), the prevalence
among multiple gestation pregnancies was not significantly increased in data from the
National Birth Defects Prevention Study [crude PR: 1.1, 95% CI: 0.4, 2.8].14
Significant associations have been reported between pregestational (but not gestational)
maternal diabetes and isolated [adjusted OR: 12.4, 95% CI: 3.7, 41.5] and non-isolated [OR:
25.3, 95% CI: 4.2, 152.1] atrioventricular septal defects in data from the National Birth
Defects Prevention Study (N=85 cases).5 An association between pregestational diabetes
and atrioventricular septal defects has also been reported in data from the EUROCAT
registry after adjustment for maternal age, year, and registry [adjusted OR: 2.2, 95% CI: 1.2,
4.0].21 Atrioventricular septal defects and CAVC have also been evaluated in data from the
Baltimore-Washington Infant Study, and significant crude associations between
pregestational diabetes and CAVC have been reported in analyses involving a small number
of cases [N=31 cases, OR: 22.8, 95% CI: 7.4, 70.5].4, 22, 23 To our knowledge, an
association between gestational diabetes and CAVC has not been previously reported.
The association between pregestational diabetes and complex heart defects involving
conotruncal septation, cardiac looping, or the endocardial cushion (as reported in our study)
points towards an early teratogenic effect on cardiac development (weeks 3–8) by an
abnormal metabolic milieu in diabetic mothers.20, 24 The biologic basis for the association
between maternal gestational diabetes, which is typically diagnosed after the first trimester,
and CAVC is difficult to explain and may reflect cases of undiagnosed pregestational
diabetes mellitus diagnosed as gestational diabetes.17, 25
Several previous studies have reported associations between prepregnancy maternal elevated
BMI or obesity and offspring risk for heart defects overall, as well as specific heart defects
(e.g., left ventricular outflow tract defects, conotruncal defects).26–28 However, maternal
obesity and CAVC has not been well studied and, to our knowledge, this is the first report of
a statistically significant association between maternal obesity and CAVC. Three studies
have, however, reported non-significant, elevated associations between elevated BMI and
atrioventricular septal defects [adjusted ORs: 1.8, 1.4, and 1.2].6, 26, 27
The novel association between CAVC in offspring and maternal unmarried status may
reflect underlying involvement of additional unknown socioeconomic or behavioral factors.
Unmarried status has been associated with other adverse pregnancy outcomes in Texas,29
and similar associations between unmarried status and heart defects overall in offspring have
been reported 30, 31 but the relationship between marital status and heart defects has not been
thoroughly evaluated.
The present study had limitations. Data for maternal obesity, pregestational diabetes, and
gestational diabetes was only available for more recent years (i.e., 2005–2008). Similar to
other studies of diabetes and birth defects,5, 23 information on type of pregestational diabetes
(i.e., type 1 or type 2), diabetes severity, glycemic control, method of diabetes diagnosis, and
clinical confirmation of diagnosis was not available. Data for pregestational, gestational, and
overall maternal diabetes and obesity were collected from vital records for cases and all
livebirths. It seems likely that maternal diabetes and obesity could be underreported on vital
records;32 however, the observed prevalence of gestational diabetes, pregestational diabetes,
and obesity from 2005–2008 among all live births (i.e., 3.7%, 0.6%, and 20.8%,
respectively, data not shown) seems reasonably similar to previous estimates (e.g., 2–10%,
0.5%, and 22%, respectively).5, 33–35 Further, previously reported associations between
maternal diabetes or obesity and other heart defects support our findings. We cannot rule out
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the presence of unmeasured confounding by other factors, as our analyses were limited to
available data.
There are several strengths to this study, including use of a population-based, multiracial/
ethnic sample ascertained by an active surveillance system that includes both liveborn and
non-liveborn cases. To our knowledge, this descriptive study contains the largest sample of
cases with CAVC described in the literature. We attempted to limit heterogeneity by
restricting our case definition to a subset of endocardial cushion defects (i.e., CAVC), and
by restricting analyses to nonsyndromic cases. Results for our subgroup analyses also
support the main results, and suggest that maternal diabetes and obesity increase offspring
risk for CAVC independently of heterotaxy.
In summary, we have identified maternal factors that may increase risk for CAVC. The
observed associations between CAVC in offspring and maternal pregestational diabetes,
gestational diabetes, and obesity seem consistent with previous findings. Further research is
indicated to confirm our findings and better understand the biological mechanisms that
underlie these associations.
Supplementary Material
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Table 1
Distribution of Endocardial Cushion Defects and Specified Syndromic and Nonsyndromic Subgroups.
Endocardial cushion defect type and subgroup N (%)
CAVCa 1,335
 Syndromic 772 (57.8)
  Trisomy 21 693 (51.9)
  Trisomy 18 31 (2.3)
  Trisomy 13 10 (0.7)
  Other chromosome abnormalities 16 (1.2)
  Other syndromes 33 (2.5)
 Nonsyndromic 563 (42.2)
  Additional cardiac or non-cardiac malformation 516
   Additional cardiac malformation only 223
    Visceral heterotaxy 218
  Isolated CAVCa 47
 CAVCa and single or hypoplastic ventricle variants 287
  Trisomy 21 49 (17.1)
  Nonsyndromic 221 (77.0)
Ostium primum defects without CAVCa 143
 Trisomy 21 34 (23.8)
 Nonsyndromic 95 (66.4)
Single common atrium 106
 Trisomy 21 3 (2.8)
 Nonsyndromic 86 (81.1)
Other endocardial cushion defect 62
 Trisomy 21 27 (43.5)
 Nonsyndromic 30 (48.4)
aComplete atrioventicular canal defects
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Table 2
Additional Major Birth Defects Among Nonsyndromic Cases with Complete Atrioventricular Canal Defects
(N=563)
Major birth defecta N %
Additional cardiovascular anomalies
Septal defects
 Additional ventricular septal defect 61 10.8
 Secundum atrial septal defect 183 32.5
Conotruncal defects
 Tetralogy of Fallot 18 3.2
 Pulmonary infundibular stenosis, not otherwise specified 56 9.9
 Transposition of great vessels 222 39.4
 Common truncus 8 1.4
Aortic arch abnormalities
 Coarctation of aorta 66 11.7
 Hypoplasia of aorta 78 13.9
 Persistent right aortic arch 106 18.8
Anomalies of great veins
 Persistent left superior vena cava 143 25.4
 Total anomalous pulmonary venous return 104 18.5
 Partial anomalous pulmonary venous return 20 3.6
Hypoplastic or single ventricle variants
 Hypoplastic left ventricle 104 18.5
 Hypoplastic right ventricle 45 8.0
 Hypoplastic ventricle, not otherwise specified 5 0.9
 Single ventricle, not otherwise specified 67 11.9
Additional specified abnormality of common atrioventricular valve
 Congenital stenosis of ‘mitral’ component 71 12.6
 Atresia or stenosis of ‘tricuspid’ component 25 4.4
Anomalies of aortic valve
 Congenital stenosis of aortic valve 30 5.3
 Congenital insufficiency of aortic valve 1 0.2
Anomalies of pulmonary valve
 Atresia, hypoplasia, or absence of pulmonary valve 75 13.3
 Stenosis of pulmonary valve 83 14.7
 Unspecified pulmonary atresia, stenosis, or hypoplasia 58 10.3
Anomalies of pulmonary artery 148 26.3
Anomalies of coronary artery or sinus 32 5.7
Additional non-cardiac birth defects
Visceral heterotaxy 218 38.7
Anomalies of nervous system 38 6.7
Anomalies of eye 10 1.8
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Major birth defecta N %
Anomalies of ear, face, and neck 34 6.0
Anomalies of respiratory system 22 3.9
Anomalies of digestive system
 Anomalies of intestinal fixation 93 16.5
 Anomalies of gallbladder, bile ducts, and liver 22 3.9
 Other specified anomalies of stomach 62 11.0
Anomalies of urinary system and genital organs 76 13.5
Anomalies of musculoskeletal system
 Polydactyly 14 2.5
 Anomalies of spine 29 5.2
 Other anomalies of ribs and sternum 28 5.0
a
Frequent additional major birth defects reported by system/structure
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TABLE 3
Prevalence Estimates and Unadjusted Prevalence Ratios for Cases with Nonsyndromic Complete
Atrioventricular Canal Defects in TX, 1999–2008
Variable Cases (N=563) Total live births(N=3,806,299)
Prevalence (/10,000
live births)
Unadjusted prevalence
ratio [95% CIa]
Maternal age (years)
 <20 79 538534 1.47 1.0 Reference
 20–24 144 1070642 1.34 0.9 [0.7, 1.2]
 25–29 149 1019564 1.46 1.0 [0.8, 1.3]
 30–34 116 762017 1.52 1.0 [0.8, 1.4]
 35–39 57 343776 1.66 1.1 [0.8, 1.6]
 ≥40 18 71377 2.52 1.7 [1.0, 2.9]
Paternal age (years)b
 <20 23 183310 1.25 1.0 Reference
 20–24 84 683788 1.23 1.0 [0.6, 1.6]
 25–29 124 872854 1.42 1.1 [0.7, 1.8]
 30–34 106 783698 1.35 1.1 [0.7, 1.7]
 35–39 72 458663 1.57 1.3 [0.8, 2.0]
 ≥40 54 267814 2.02 1.6 [1.0, 2.6]
Marital status
 Married 334 2442935 1.37 1.0 Reference
 Unmarried 220 1360777 1.62 1.2 [1.0, 1.4]
Plurality
 Singleton 538 3695793 1.46 1.0 Reference
 Multiple 25 110299 2.27 1.6 [1.0, 2.3]
Any diabetes
 Yes 48 131010 3.66 2.7 [2.0, 3.6]
 No 503 3675287 1.37 1.0 Reference
Gestational diabetesc
 Yes 15 59597 2.52 1.6 [0.9, 2.7]
 No 245 1537944 1.59 1.0 Reference
Pre-gestational diabetesc
 Yes 12 9690 12.38 7.9 [4.4, 14.2]
 No 248 1587851 1.56 1.0 Reference
Body mass index (kg/m2)c
 Underweight (<18.5) 9 72441 1.24 0.9 [0.5, 1.8]
 Normal (18.5–24.9) 105 788537 1.33 1.0 Reference
 Overweight (25.0–29.9) 70 393053 1.78 1.3 [1.0, 1.8]
 Obese (≥30) 75 329813 2.27 1.7 [1.3, 2.3]
Previous live births
 No 222 1443081 1.54 1.0 Reference
 Yes 340 2271640 1.50 1.0 [0.8, 1.2]
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Variable Cases (N=563) Total live births(N=3,806,299)
Prevalence (/10,000
live births)
Unadjusted prevalence
ratio [95% CIa]
Previous pregnancies that did not result in
live births
 No 428 2991926 1.43 1.0 Reference
 Yes 119 754571 1.58 1.1 [0.9, 1.4]
Year of delivery
 1999 51 349157 1.46 1.0 Reference
 2000 42 363325 1.16 0.8 [0.5, 1.2]
 2001 49 365092 1.34 0.9 [0.6, 1.4]
 2002 57 372369 1.53 1.1 [0.7, 1.5]
 2003 43 377374 1.14 0.8 [0.5, 1.2]
 2004 57 381441 1.49 1.0 [0.7, 1.5]
 2005 55 385537 1.43 1.0 [0.7, 1.4]
 2006 71 399309 1.78 1.2 [0.9, 1.7]
 2007 63 407453 1.55 1.1 [0.7, 1.5]
 2008 75 405242 1.85 1.3 [0.9, 1.8]
Sex
 Male 288 1945841 1.48 1.0 Reference
 Female 275 1860458 1.48 1.0 [0.9, 1.2]
Maternal education
 >High school 199 1473279 1.35 1.0 Reference
 High school 175 1109945 1.58 1.2 [1.0, 1.4]
 <High school 173 1183477 1.46 1.1 [0.9, 1.3]
Maternal Residence (Texas-Mexico
border)
 No 482 3318005 1.45 1.0 Reference
 Yes 81 488294 1.66 1.1 [0.9, 1.4]
Maternal race/ethnicity
 Non-Hispanic white 205 1387934 1.48 1.0 Reference
 Non-Hispanic black 67 424964 1.58 1.1 [0.8, 1.4]
 Hispanic 280 1844103 1.52 1.0 [0.9, 1.2]
Paternal race/ethnicityc
 Non-Hispanic white 176 1222703 1.44 1.0 Reference
 Non-Hispanic black 46 330461 1.39 1.0 [0.7, 1.3]
 Hispanic 225 1563780 1.44 1.0 [0.8, 1.2]
Season of conception
 Winter 158 923181 1.71 1.0 Reference
 Spring 122 873593 1.40 0.8 [0.6, 1.0]
 Summer 117 849111 1.38 0.8 [0.6, 1.0]
 Fall 150 916132 1.64 1.0 [0.8, 1.2]
First trimester prenatal care
 Yes 376 2696236 1.39 1.0 Reference
 No 145 919749 1.58 1.1 [0.9, 1.4]
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Variable Cases (N=563) Total live births(N=3,806,299)
Prevalence (/10,000
live births)
Unadjusted prevalence
ratio [95% CIa]
Residence type
 Metropolitan urbanized 502 3387886 1.48 1.0 Reference
 Non-metropolitan urbanized 30 155328 1.93 1.3 [0.9, 1.9]
 Less urbanized 31 263085 1.18 0.8 [0.6, 1.1]
Maternal birthplaced
 United States 148 922218 1.60 1.1 [0.9, 1.4]
 Outside United States 132 921885 1.43 1.0 Reference
Total 563 3806299 1.48
aCI, confidence interval
b
Data were missing for 17.8% of cases for paternal age and 20.6% for paternal race/ethnicity
c
Data available for cases delivered in 2005–2008 only
d
Maternal birthplace was only analyzed among cases with Hispanic mothers
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